AtriCure (ATRC) Net Shares Issued and Repurchased (2011 - 2020)
AtriCure's (ATRC) quarterly Net Shares Issued and Repurchased came in at $450000.0 in Q4 2020, up 971.43% year-over-year from $42000.0 in Q1 2020, and up 971.43% quarter-over-quarter from $42000.0 in Q4 2019.
Analysis
AtriCure (ATRC) Net Shares Issued and Repurchased (2011 - 2020) Analysis & Trends
AtriCure (ATRC) has reported Net Shares Issued and Repurchased for 10 consecutive years, with $450000.0 the latest figure, recorded in Q4 2020.
- On a quarterly basis, Net Shares Issued and Repurchased rose 971.43% year-over-year to $450000.0 in Q4 2020; TTM through Dec 2020 was $450000.0, a 971.43% increase from a year earlier, with the FY2020 full-year figure at $450000.0, up 971.43% from the prior year.
- Net Shares Issued and Repurchased was $450000.0 for Q4 2020 at AtriCure, up from $42000.0 in the prior quarter.
- Over five years, Net Shares Issued and Repurchased peaked at $450000.0 in Q4 2020 and troughed at $42000.0 in Q4 2019.
- A 5-year average of $208400.0 and a median of $91000.0 in 2018 frame the typical range for Net Shares Issued and Repurchased.
- Across the five-year window, Net Shares Issued and Repurchased slumped 83.5% in 2017 and soared 971.43% in 2020, its largest moves.
- Over 5 years, Net Shares Issued and Repurchased stood at $394000.0 in 2016, then tumbled by 83.5% to $65000.0 in 2017, then surged by 40.0% to $91000.0 in 2018, then tumbled by 53.85% to $42000.0 in 2019, then soared by 971.43% to $450000.0 in 2020.
- The last three Net Shares Issued and Repurchased figures came in at $450000.0 (Q4 2020), $42000.0 (Q4 2019), and $91000.0 (Q4 2018), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Shares Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | - |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | - |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | - |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | - |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | - |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | - |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | - |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | - |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | - |
| 10 | AtriCure | 2.58 Bn | 2.41 Bn | 118.63 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2020 | 450,000.00 |
| Dec 31, 2019 | 42,000.00 |
| Dec 31, 2018 | 91,000.00 |
| Dec 31, 2017 | 65,000.00 |
| Dec 31, 2016 | 394,000.00 |
| Dec 31, 2015 | 228,000.00 |
| Dec 31, 2014 | 603,000.00 |
| Sep 30, 2014 | 592,000.00 |
| Mar 31, 2014 | 488,000.00 |
| Dec 31, 2013 | 912,000.00 |
| Mar 31, 2013 | 576,000.00 |
| Dec 31, 2012 | 972,000.00 |
| Dec 31, 2011 | 264,000.00 |